---
category: news
title: "Kiromic BioPharma Reports Favorable Deltacel™ Preclinical Pharmacology Results"
excerpt: "Kiromic BioPharma, Inc. (NASDAQ: KRBP) (\"Kiromic\" or the \"Company\"), a clinical-stage fully-integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence and data mining platform to develop cell therapies with a focus on immune-oncology,"
publishedDateTime: 2023-02-28T15:12:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-kiromic-biopharma-reports-favorable-deltaceltrade-preclinical-pharmacology-resul-/2023/02/28/9767757.htm"
webUrl: "https://www.tmcnet.com/usubmit/-kiromic-biopharma-reports-favorable-deltaceltrade-preclinical-pharmacology-resul-/2023/02/28/9767757.htm"
type: article
quality: 0
heat: -1
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Lantern Pharma and TTC Oncology Establish AI Collaboration to Expand the Clinical Development of Drug Candidate TTC-352"
    excerpt: "Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence (\"AI\") and machine learning (“ML”) platform to transform the cost, pace,"
    publishedDateTime: 2023-02-27T11:59:00Z
    webUrl: "https://markets.buffalonews.com/buffnews/article/bizwire-2023-2-27-lantern-pharma-and-ttc-oncology-establish-ai-collaboration-to-expand-the-clinical-development-of-drug-candidate-ttc-352"
    type: article
    provider:
      name: The Buffalo News
      domain: buffalonews.com
    quality: 0

secured: "8l5Oy5T959Iy7KYpIXhAESQ3mgSi8vB6SUyl1PcsRdoRtibnRSq2Kn4R95+HH2G2xCczDMEbWN5bwnOmKB4HEORlNf9lmgX/bathgD0WFkVVk0s6osif04VmVFNMEgy6y8KnmUyAD8LM/gTOjhRK6Y34Nz8IcWcqQY9j5txRL3jYXK8rpb0VapwMQGq47+nHvDKSPSMjvxtnWmUQJiVLjq8q2NYwvdvvlQ/HqwHNGZovh9lngEwUYxz4FRCk5h/S9YvTmEE43Tn5g6j14IUxlAeys5jvugynEpDOfhH+vcV/QH4o/blXTO580agQ7vtjbEm89r2VLdt8q3MYBkWLBm9TiUE1zWIXbxQFCs/GtEk=;GAc77Jmmg0thT8HxGzFi/g=="
---

